| Structure |
Chemical Name |
CAS |
MF |
 |
Umeclidinium Impurity 3 |
869113-45-1 |
C29H32BrNO3 |
 |
Ixazomib Impurity 2 |
|
|
 |
sildenafil impurity I |
|
C22H30N6O4S |
 |
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
 |
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
 |
8-Hydroxy Entecavir |
1795791-10-4 |
C12H15N5O4 |
![1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)-](/CAS/20180527/GIF/1404559-22-3.gif) |
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
|
|
Ampicillin Impurity A |
|
|
|
|
Oxacillin Sodium Impurity B(EP) |
|
|
 |
3,5-dichlorothiophene-2-carboxylic acid |
89166-94-9 |
C5H2Cl2O2S |
 |
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
![2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid](/CAS/20180527/GIF/80047-38-7.gif) |
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
80047-38-7 |
C12H10N2O3 |
![4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20180629/GIF/942195-83-7.gif) |
4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid |
942195-83-7 |
C16H14N2O3 |
|
|
Tofacitinib Impurity G |
|
|
 |
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |
 |
Ceftaroline Fosamil Impurity 6 |
953037-71-3 |
C22H20N8O5S4 |
 |
Zolmitriptan Related Compound F |
1350928-05-0 |
C38H53N7O4 |
|
|
Moxifloxacin EP Impurity E HCl |
|
|
![4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butan-1-ol](/CAS/20180629/GIF/913614-15-0.gif) |
4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butan-1-ol |
913614-15-0 |
C16H22N2OS |
 |
3-((methoxycarbonyl)methyl)-5-methylhexanoic acid |
181289-11-2 |
C10H18O4 |
 |
Cyanocobalamin Impurity F |
23208-66-4 |
C63H85CoN13O15P |
|
|
Nintedanib Impurity G (Intedanib Impurity G) |
|
|
|
|
Canagliflozin alpha-Isomer Impurity |
|
|
|
|
Dapagliflozin Impurity 4 |
|
|
|
|
Isavuconazole Impurity 9 |
|
|
 |
Bisoprolol EP Impurity N |
1346601-75-9 |
C17H29NO4 |
|
|
Rosuvastatin EP Impurity J |
|
|
 |
Bosutinib Impurity |
380843-12-9 |
C19H15Cl2N3O3 |
 |
Pantoprazole Impurity 11 |
172282-50-7 |
C7H8F2N2O |
 |
Solifenacin Related Compound 24 |
1682642-69-8 |
C15H23ClN2 |
 |
Ticagrelor Related Compound 44 |
1431867-40-1 |
C8H12ClN3OS |
 |
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1006614-51-2 |
C10H9F2NO |
 |
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride |
1640971-87-4 |
C10H18ClN3O |
 |
6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C17H17N5 |
 |
WPDCFRNNHUYQGW-IUXPMGMMSA-N |
1628639-06-4 |
C21H23NO4 |
 |
tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
521974-00-5 |
C13H23ClO4 |
 |
Cefadroxil Sulfoxide |
182290-77-3 |
C16H17N3O6S |
 |
GSFIWDGFHNAUFU-UHFFFAOYSA-N |
2125702-80-7 |
C16H29N5O4 |
 |
2,5-dichloro-N,N-dimethylbenzamide |
90526-01-5 |
C9H9Cl2NO |
 |
Ibrutinib Impurity 9 |
2068022-09-1 |
C25H21D5N6O4 |
 |
4-クロロ-3-ヒドロキシブチロニトリル |
105-33-9 |
C4H6ClNO |
 |
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
 |
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
 |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
![2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID](/CAS/GIF/60091-87-4.gif) |
2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID |
60091-87-4 |
C13H9ClN2O4 |
|
|
Fulvestrant impurity I |
|
|
 |
Emtricitabine |
61548-81-0 |
C11H22O3S |
 |
tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate |
608142-93-4 |
C14H20N4O4 |
![4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE](/CAS/GIF/29489-04-1.gif) |
4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE |
29489-04-1 |
C17H16BrNO3S |
|
|
Peramivir Impurity 58 |
|
|
 |
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-rel- |
2124277-87-6 |
C17H17Cl2N |
|
|
Norfloxacin iMpurity E |
|
|
|
|
Posaconazole iMpurity 2 |
|
|
![Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol]](/CAS/20200611/GIF/2206135-50-2.gif) |
Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] |
2206135-50-2 |
C25H18N2S2 |
 |
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide |
294852-91-8 |
C18H22N2O |
![N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine](/CAS/20180629/GIF/1052691-22-1.gif) |
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
 |
3-pentylisoindolin-1-one |
691863-84-0 |
C13H17NO |
![(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180629/GIF/1598416-05-7.gif) |
(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-05-7 |
C22H20N2O5 |
 |
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride |
|
C33H28ClF2N5O4S2 |
 |
Labetalol EP impurity D |
32780-65-7 |
C9H13ClN2O3 |
|
|
Voriconazole toxic impurity 2 |
|
|
 |
Cisatracurium besylate impurity19 |
96946-52-0 |
C59H77N2O15S+ |
|
|
Bumetanide Impurity 3 |
|
|
|
|
Cefoxitin EP Impurity F (S-methoxy cefoxitin) |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2514949-81-4 |
C20H28N4O2 |
![α-[4-[2-(ジメチルアミノ)エトキシ]フェニル]-β-エチル-α-フェニルベンゼンエタノール](/CAS/GIF/748-97-0.gif) |
α-[4-[2-(ジメチルアミノ)エトキシ]フェニル]-β-エチル-α-フェニルベンゼンエタノール |
748-97-0 |
C26H31NO2 |
|
|
Brivaracetam Impurity 53 |
|
|
 |
(2R,3R)-2,3-ジヒドロキシブタン二酸1-エチル |
608-89-9 |
C6H10O6 |
 |
2,2,4-トリクロロ-3-オキソブタン酸エチル |
85153-67-9 |
C6H7Cl3O3 |
|
|
neo-ジゴキシン |
55576-67-5 |
C41H64O14 |
|
|
(S)-6-((R)-2-amino-2-phenylacetamido)-2,2-dimethyl-7-oxo-2,3,4,7-tetrahydro-1,4-thiazepine-3-carboxylic acid |
|
|
|
|
Rabeprazole iMpurity (Chloro interMediate) |
|
|
 |
TaMsulosin IMpurity F |
|
C20H28N2O5S |
 |
TiaMulin IMpurity E (TiaMulone,11-Oxo TiaMulin) |
113323-39-0 |
C28H45NO4S |
![2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol](/CAS/20150408/GIF/848814-27-7.gif) |
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol |
848814-27-7 |
C21H27N3O3S |
![(3AR,7R,7AR)-2,2-ジエチル-3A,6,7,7A-テトラヒドロ-7-[(メチルスルホニル)オキシ]-1,3-ベンゾジオキソール-5-カルボン酸エチルエステル](/CAS/20150408/GIF/204254-90-0.gif) |
(3AR,7R,7AR)-2,2-ジエチル-3A,6,7,7A-テトラヒドロ-7-[(メチルスルホニル)オキシ]-1,3-ベンゾジオキソール-5-カルボン酸エチルエステル |
204254-90-0 |
C15H24O7S |
 |
TorseMide Carboxylic Acid |
113844-99-8 |
C16H18N4O5S |
 |
(6-BroMo-2-ethyl-3-benzofuranyl)(3,5-dibroMo-4-hydroxyphenyl)Methanone |
1402819-05-9 |
C17H11Br3O3 |
![5'-broMo-[2,3'-bipyridin]-6'(1'H)-one](/CAS/20150408/GIF/381233-79-0.gif) |
5'-broMo-[2,3'-bipyridin]-6'(1'H)-one |
381233-79-0 |
C10H7BrN2O |
 |
1-((2R,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one |
2243786-01-6 |
C30H35N5O3 |
 |
5-(3-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
 |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(1-methylethyl) ester |
21881-78-7 |
C21H26N2O6 |
 |
4-メチルベンゼンスルホン酸2-ヒドロキシエチル |
42772-85-0 |
C9H12O4S |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-94-6.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-94-6 |
C18H25N3O2 |
|
|
EMpagliflozin iMpurity 8 |
|
|
 |
EMpagliflozin iMpurity 13 |
2125472-55-9 |
C23H25ClO8 |
 |
6-Methyldi(ondansetron-3-de(1,2-diMethyl-1H-iMidazole)) |
1365727-07-6 |
C27H26N2O2 |
 |
Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) |
910299-74-0 |
C19H24O4 |
 |
Etoricoxib Impurity 12 |
646459-41-8 |
C21H16ClN3O2S |
 |
Levofloxacin Tetrafluoro Impurity 2 |
103995-33-1 |
C14H12F4O4 |
 |
Mupirocin Impurity C |
|
C26H44O9 |
![2-(3,4-ジメトキシフェニル)-2-エチル-5-[メチル[2-(3,4-ジメトキシフェニル)エチル]アミノ]-ペンタンニトリル](/CAS/20180703/GIF/67018-83-1.gif) |
2-(3,4-ジメトキシフェニル)-2-エチル-5-[メチル[2-(3,4-ジメトキシフェニル)エチル]アミノ]-ペンタンニトリル |
67018-83-1 |
C26H36N2O4 |
 |
Parecoxib Impurity C |
3026677-40-4 |
|
 |
RAC アトモキセチン塩酸塩 |
82857-40-7 |
C17H22ClNO |
 |
3-(1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
943320-48-7 |
C10H8F3N3 |
 |
Linagliptin Impurity H |
1646355-34-1 |
C22H23N7O2 |
 |
Ezetimibe Impurity 54 |
1185883-39-9 |
C40H36F2N2O5 |
 |
2-(2-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
1348664-75-4 |
C13H13FN6O |
|
|
Dapagliflozin Impurity 2 |
|
|
|
|
Imatinib Impurity 1 |
|
|